Therapeutic targeting of mismatch repair proteins in triplet repeat expansion diseases
- 15 February 2025
- journal article
- review article
- Published by Elsevier in DNA Repair
- Vol. 147, 103817
Abstract
No abstract availableKeywords
This publication has 88 references indexed in Scilit:
- Genetic and Functional Analyses Point to FAN1 as the Source of Multiple Huntington Disease Modifier EffectsThe American Journal of Human Genetics, 2020
- DNA repair in cancer initiation, progression, and therapy—a double-edged swordJournal of Applied Genetics, 2019
- Exome Sequencing Identifies Biallelic MSH3 Germline Mutations as a Recessive Subtype of Colorectal Adenomatous PolyposisThe American Journal of Human Genetics, 2016
- Identification of Genetic Factors that Modify Clinical Onset of Huntington’s DiseaseCell, 2015
- Striatal Volume Contributes to the Prediction of Onset of Huntington Disease in Incident CasesBiological Psychiatry, 2012
- Delineation of Joint Molecule Resolution Pathways in Meiosis Identifies a Crossover-Specific ResolvaseCell, 2012
- Basal ganglia volume and clinical correlates in ‘preclinical’ Huntington’s diseaseJournal of Neurology, 2008
- Endonucleolytic Function of MutLα in Human Mismatch RepairCell, 2006
- Msh3 is a limiting factor in the formation of intergenerational CTG expansions in DM1 transgenic miceHuman Genetics, 2006
- Trinucleotide repeats that expand in human disease form hairpin structures in vitroCell, 1995